Buljubasic Nermina, Akkerhuis K Martijn, Cheng Jin M, Oemrawsingh Rohit M, Garcia-Garcia Hector M, de Boer Sanneke P M, Regar Evelyn, van Geuns Robert-Jan M, Serruys Patrick W J C, Boersma Eric, Kardys Isabella
Department of Cardiology, Erasmus MC, Rotterdam, the Netherlands.
Coron Artery Dis. 2017 Jan;28(1):23-32. doi: 10.1097/MCA.0000000000000442.
The aim of this study was to provide additional insight into the role of fibrinogen in coronary artery disease by investigating the associations between plasma fibrinogen with both degree and composition of coronary atherosclerosis as determined by virtual histology-intravascular ultrasound.
In 581 patients undergoing coronary angiography for acute coronary syndrome (ACS) or stable angina pectoris, preprocedural blood samples were drawn for fibrinogen, C-reactive protein (CRP), interleukin-6, and plasminogen activator inhibitor-1 measurements, and virtual histology-intravascular ultrasound of a nonculprit coronary artery was performed. The degree [plaque volume, plaque burden (PB), and lesions with PB≥70%] and the composition of coronary atherosclerotic plaque (fibrous, fibrofatty, dense calcium, necrotic core tissue, and thin-cap fibroatheroma lesions) were assessed.
Fibrinogen showed a tendency toward a positive association with PB [β (95% CI): 2.55 (-0.52-5.61) increase in PB per ln(g/l) fibrinogen, P=0.09], which was driven significantly by an association in the ACS subgroup [β (95% CI): 4.11 (0.01-8.21) increase in PB per ln(g/l) fibrinogen, P=0.049]. Fibrinogen was also related to the presence of lesions with PB 70% or more in both the full cohort [OR (95% CI): 2.27 (1.17-4.43), P=0.016] and ACS patients [OR (95% CI): 2.92 (1.17-7.29), P=0.022]. All associations were independent of established cardiovascular risk factors, but not CRP. Interleukin-6 and plasminogen activator inhibitor-1 did not provide incremental value to fibrinogen when examining the associations with degree of atherosclerosis. Substantial associations with plaque composition were absent.
Fibrinogen is associated with degree of coronary atherosclerosis, especially in ACS patients. However, whether this association is independent of CRP might be questioned and needs further investigation.
本研究旨在通过调查血浆纤维蛋白原与虚拟组织学血管内超声测定的冠状动脉粥样硬化程度和成分之间的关联,进一步深入了解纤维蛋白原在冠状动脉疾病中的作用。
对581例因急性冠状动脉综合征(ACS)或稳定型心绞痛接受冠状动脉造影的患者,在术前采集血样测定纤维蛋白原、C反应蛋白(CRP)、白细胞介素-6和纤溶酶原激活物抑制剂-1,并对非罪犯冠状动脉进行虚拟组织学血管内超声检查。评估冠状动脉粥样硬化斑块的程度[斑块体积、斑块负荷(PB)以及PB≥70%的病变]和成分(纤维、纤维脂肪、致密钙、坏死核心组织和薄帽纤维粥样瘤病变)。
纤维蛋白原与PB呈正相关趋势[β(95%CI):纤维蛋白原每ln(g/l)增加,PB增加2.55(-0.52 - 5.61),P = 0.09],这在ACS亚组中显著相关[β(95%CI):纤维蛋白原每ln(g/l)增加,PB增加4.11(0.01 - 8.21),P = 0.049]。纤维蛋白原在整个队列[比值比(95%CI):2.27(1.17 - 4.43),P = 0.016]和ACS患者[比值比(95%CI):2.92(1.17 - 7.29),P = 0.022]中也与PB≥70%的病变存在有关。所有关联均独立于已确定的心血管危险因素,但与CRP无关。在检查与动脉粥样硬化程度的关联时,白细胞介素-6和纤溶酶原激活物抑制剂-1对纤维蛋白原没有额外价值。与斑块成分无显著关联。
纤维蛋白原与冠状动脉粥样硬化程度相关,尤其是在ACS患者中。然而,这种关联是否独立于CRP可能存在疑问,需要进一步研究。